Razi Journal of Medical Sciences

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

---

Most infectious bacteria can at least be resistant to some antibiotics. Moreover, Drug resistant bacteria are known as multi-resistance organisms. Nowadays, the urgently need for new strategies is increasingly felt to control bacterial activity and in this regard, a very promising approach can be nanomaterials. Today's knowledge of nanoscale synthesis has to be considered as a global strategy. Nanotechnology includes the engineering and manufacturing of materials at the atomic and molecular scale and it refers to structures of about 1-100 nm in at least one dimension. In addition to nanotechnology applications, we can mention the new science of nanomedicine, which we are currently seeing its enormous effects in the pharmaceutical and medical biotechnology industries. This science is rapidly becoming a major driving force in the field of antimicrobial activity in the world. This paper focuses on the use of nanotechnology as a new tool for tackling the current challenges in the field of infectious disease treatment. Therefore, for safer use of this new technology, clinical trials and further research are needed at the molecular biology level. Ultimately, the adverse effects of nanomaterials cannot be ruled out.

Keywords: Antimicrobials drug, Drug resistance, Nanomaterials, Nanostructures

Full-Text [PDF 1307 kb]   (3049 Downloads)    

Add your comments about this article : Your username or Email:

---

---